![]() |
||||
|
||||
|
|
||||
Re: Maternal deaths, and risk of misoprostol for missed ABFrom: igold@cox.netSat Mar 18 11:20:06 2006
Actually, if you read the link Fran sent, it infers that misoprostol is the problem. I actually heard on the NPR report that this was the case also. Ingrid > > From: "Gerald P. Rodríguez" <geraldpr@cybermesa.com> > Date: 2006/03/18 Sat PM 01:17:24 EST > To: Multiple recipients of list OB-GYN-L <ob-gyn-l@dns.obgyn.net> > Subject: Re: Maternal deaths, and risk of misoprostol for missed AB > > Today's Wall Street Journal reports that Planned Parenthood in Washington DC > said yesterday that it was changing its prescribing practices for the use of > MIFEPRISTONE (Mifprex) (RU-486) in light of two recent maternal deaths > associated with its use vaginally instead of orally. Its vaginal use is > off-label and this practice is now being implicated in the death of 6 total > patients from sepsis. > > Gerald P. Rodríguez, M.D., FACOG > Santa Fe > > ~~~~~~~~~~~~~ > Quien calla otorga. > ~~~~~~~~~~~~~~ > ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
>> ----- Original Message -----
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Tue Feb 2 05:07:42 2010 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.